Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

1.2K
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.2K
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

1.1K
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
1.1K
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

395
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
395
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

826
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
826
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

359
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
359
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

544
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
544

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Practical Guide to Target Trial Emulation: Connecting Randomized Trials and Real-World Data in Cardiovascular Research.

European journal of preventive cardiology·2026
Same author

Transforming hypertension management with digital technology: a retrospective cohort study in four sub-Saharan African countries.

BMJ public health·2026
Same author

Patient perspective on the management of hypertension in 7 European countries: insights from a survey of 4001 patients.

Polish archives of internal medicine·2026
Same author

Combined response to letters to the editors.

Gut·2026
Same author

Prevention of secondary infections by interferon-gamma in ICU-acquired sustained immune suppression in France: study protocol of the PLATINIUM randomised trial.

BMJ open·2026
Same author

Cardiovascular risk assessment and risk factor control in patients with hypertension in Europe: the SNAPSHOT study.

European heart journal. Quality of care & clinical outcomes·2026

Related Experiment Video

Updated: Mar 21, 2026

Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research
06:51

Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research

Published on: October 20, 2023

1.8K

Low-gradient aortic stenosis.

Marie-Annick Clavel1, Julien Magne2, Philippe Pibarot3

  • 1Québec Heart and Lung Institute/Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, 2725 Chemin Sainte Foy, #A-2075, QC, Canada G1V4G5.

European Heart Journal
|May 19, 2016
PubMed
Summary
This summary is machine-generated.

Managing low-gradient aortic stenosis (AS) is challenging due to conflicting severity indicators. Differentiating true severe AS from pseudo-severe AS guides treatment decisions for better patient outcomes.

Keywords:
Aortic stenosisAortic valve replacementComputed tomographyEchocardiographyLow flowLow gradientTranscatheter aortic valve replacement

More Related Videos

O-Ring Aortic Banding Versus Traditional Transverse Aortic Constriction for Modeling Pressure Overload-Induced Cardiac Hypertrophy
09:24

O-Ring Aortic Banding Versus Traditional Transverse Aortic Constriction for Modeling Pressure Overload-Induced Cardiac Hypertrophy

Published on: October 6, 2022

4.4K
Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

12.0K

Related Experiment Videos

Last Updated: Mar 21, 2026

Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research
06:51

Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research

Published on: October 20, 2023

1.8K
O-Ring Aortic Banding Versus Traditional Transverse Aortic Constriction for Modeling Pressure Overload-Induced Cardiac Hypertrophy
09:24

O-Ring Aortic Banding Versus Traditional Transverse Aortic Constriction for Modeling Pressure Overload-Induced Cardiac Hypertrophy

Published on: October 6, 2022

4.4K
Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

12.0K

Area of Science:

  • Cardiology
  • Echocardiography
  • Cardiac Imaging

Background:

  • Low-gradient aortic stenosis (AS) presents a diagnostic challenge with a small aortic valve area (AVA) but low transvalvular gradient.
  • This discrepancy creates uncertainty regarding the actual severity of AS and the need for aortic valve replacement (AVR).
  • Low-gradient AS encompasses classical low-flow, low-gradient (LF-LG) AS, paradoxical LF-LG AS, and normal-flow, low-gradient (NF-LG) AS.

Purpose of the Study:

  • To clarify the diagnostic strategies for differentiating true severe AS from pseudo-severe AS in patients with low-gradient AS.
  • To guide management decisions, particularly the indication for AVR in symptomatic patients or those with left ventricular dysfunction.

Main Methods:

  • Low-dose dobutamine stress echocardiography is utilized for classical LF-LG AS assessment.
  • Multi-detector computed tomography (MDCT) with aortic valve calcium scoring is preferred for paradoxical LF-LG AS and NF-LG AS.
  • Clinical evaluation including symptoms and left ventricular ejection fraction (LVEF) is crucial.

Main Results:

  • Accurate differentiation of true severe AS is essential for appropriate AVR indication.
  • Patients with LF-LG severe AS show improved survival after AVR despite potentially worse outcomes compared to high-gradient AS.
  • Transcatheter AVR may offer superior outcomes in LF-LG AS patients compared to surgical AVR.

Conclusions:

  • Effective management of low-gradient AS relies on precise severity assessment using echocardiography and MDCT.
  • Aortic valve replacement provides survival benefits for patients with true severe LF-LG AS.
  • Further research into transcatheter AVR for LF-LG AS is warranted.